Citric Acid Monohydrate
CAS 5949-29-1
Citric Acid Monohydrate (CAS 5949-29-1) is a pharmaceutical compound with 0 bioactivity targets and 169 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Drug Names / RxNorm
Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.
| Name | RxCUI | Type | Source |
|---|---|---|---|
| Citric Acid | 21183 | SU | MTHSPL |
| citric acid | 21183 | SU | MTHSPL |
| CITRIC ACID | 21183 | SU | MTHSPL |
| Citric Acid Monohydrate | 221079 | SU | MTHSPL |
| CITRIC ACID MONOHYDRATE | 221079 | SU | MTHSPL |
| citric acid monohydrate | 221079 | SU | MTHSPL |
| Citric acid monohydrate | 221079 | SU | MTHSPL |
| citric acid monohydrate | 221079 | PIN | RXNORM |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Citric Acid Monohydrate used for in pharmaceutical contexts?
Citric Acid Monohydrate (CAS 5949-29-1) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Citric Acid Monohydrate?
Citric Acid Monohydrate has 169 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Abdominal distension, Acute hepatic failure, Acute kidney injury, Anaemia, Anuria. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Citric Acid Monohydrate also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Citric Acid Hydrate with EU status "permitted".
What clinical phase is Citric Acid Monohydrate in?
No phase 1-4 clinical development badge is rendered for Citric Acid Monohydrate because the matched compound identifier rows do not contain a max-phase value.